Optimum Medical

optimummedical.co.uk

Optimum Medical are a UK based healthcare manufacturer, specialising in healthcare lubricant gel and urology products. You'll find our products in more than 60 countries around the world - as well as every single NHS hospital in the UK. Our products aim to influence, support and improve the quality of healthcare around the world. We listen to our customer’s needs and respond by continually developing new products and evolving our existing ranges. Our products are designed to ensure patient outcomes and patient care is the best it can possibly be.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industry Outlook

BIOMEDICAN ENTERS THE ASTAXANTHIN MARKET THROUGH BIOSYNTHESIS PLATFORM TO TARGET HIGH-VALUE COMPOUND AND DISRUPT THE CURRENT TECHNOLOGIES

BIOMEDICAN | December 03, 2020

news image

BIOMEDICAN, a biotech organization planning patented minimal methods for developing high-value compounds at scale with proprietary yeasts, has entered the Astaxanthin market to diversify products outside of Cannabinoids. This new advancement permits BIOMEDICAN's biosynthesis platform to focus on any high-value compound and fundamentally disturb the current advances. Astaxanthin is a widely used, high-value compound known as a powerful antioxidant and anti-inflammatory. The Ast...

Read More

Cell and Gene Therapy

CAPSTAN THERAPEUTICS LAUNCHES WITH $165 MILLION TO DELIVER ON THE CLINICAL PROMISE OF PRECISE IN VIVO CELL ENGINEERING

Capstan | September 15, 2022

news image

Capstan Therapeutics, Inc., a biotechnology company dedicated to developing and delivering precise in vivo cell engineering to patients, launched today with $165 million in financing to build on the foundational insights of world-renowned leaders in mRNA and cell therapy, combining the power of cell therapy with the precision of genetic medicines to help bring safer, first-in-class medicines to more patients in multiple indications. Capstan’s foundational precision in vivo e...

Read More

Industrial Impact, Medical

CELULARITY AND CH TRADING GROUP DECLARES TERRITORY DISTRIBUTION AGREEMENT

Celularity | January 17, 2023

news image

Celularity Inc., a biotechnology firm based in the United States that develops placental-derived allogenic cell treatments and biomaterials, and CH Trading Group LLC, an international import, export, and trading corporation, have agreed to an exclusive territorial distribution agreement. CH Trading Group will serve as the exclusive territorial distributor for halal-certified products previously announced by Celularity in over 100 countries. The product distribution agreement for...

Read More

RELAY THERAPEUTICS ANNOUNCES FORMATION OF ONCOLOGY ADVISORY BOARD

BioSpace | March 04, 2020

news image

Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, announced today the appointment of top oncology experts, scientists and leaders to its newly formed oncology advisory board. “We are at a pivotal moment in the company’s growth and development as we become a clinical-stage company and we are delighted to have such an esteemed group of leaders to advise and support our team,” said Don Bergstrom, M.D., Ph.D., executive vice pre...

Read More
news image

Industry Outlook

BIOMEDICAN ENTERS THE ASTAXANTHIN MARKET THROUGH BIOSYNTHESIS PLATFORM TO TARGET HIGH-VALUE COMPOUND AND DISRUPT THE CURRENT TECHNOLOGIES

BIOMEDICAN | December 03, 2020

BIOMEDICAN, a biotech organization planning patented minimal methods for developing high-value compounds at scale with proprietary yeasts, has entered the Astaxanthin market to diversify products outside of Cannabinoids. This new advancement permits BIOMEDICAN's biosynthesis platform to focus on any high-value compound and fundamentally disturb the current advances. Astaxanthin is a widely used, high-value compound known as a powerful antioxidant and anti-inflammatory. The Ast...

Read More
news image

Cell and Gene Therapy

CAPSTAN THERAPEUTICS LAUNCHES WITH $165 MILLION TO DELIVER ON THE CLINICAL PROMISE OF PRECISE IN VIVO CELL ENGINEERING

Capstan | September 15, 2022

Capstan Therapeutics, Inc., a biotechnology company dedicated to developing and delivering precise in vivo cell engineering to patients, launched today with $165 million in financing to build on the foundational insights of world-renowned leaders in mRNA and cell therapy, combining the power of cell therapy with the precision of genetic medicines to help bring safer, first-in-class medicines to more patients in multiple indications. Capstan’s foundational precision in vivo e...

Read More
news image

Industrial Impact, Medical

CELULARITY AND CH TRADING GROUP DECLARES TERRITORY DISTRIBUTION AGREEMENT

Celularity | January 17, 2023

Celularity Inc., a biotechnology firm based in the United States that develops placental-derived allogenic cell treatments and biomaterials, and CH Trading Group LLC, an international import, export, and trading corporation, have agreed to an exclusive territorial distribution agreement. CH Trading Group will serve as the exclusive territorial distributor for halal-certified products previously announced by Celularity in over 100 countries. The product distribution agreement for...

Read More
news image

RELAY THERAPEUTICS ANNOUNCES FORMATION OF ONCOLOGY ADVISORY BOARD

BioSpace | March 04, 2020

Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, announced today the appointment of top oncology experts, scientists and leaders to its newly formed oncology advisory board. “We are at a pivotal moment in the company’s growth and development as we become a clinical-stage company and we are delighted to have such an esteemed group of leaders to advise and support our team,” said Don Bergstrom, M.D., Ph.D., executive vice pre...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us